A novel tumor-associated pancreatic glycoprotein is internalized by human dendritic cells and induces their maturation

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4067-4077

  Franceschi, Cécile ^a,b   Collignon, Aurélie ^a,b   Isnardon, Daniel ^c   Benkoel, Liliane ^a,b   Vérine, Alain ^a,b   Silvy, Françoise ^a,b   Bernard, Jean Paul ^a,b,d   Lombardo, Dominique ^a,b,d   Beraud, Evelyne ^a,b   Olive, Daniel ^c,e   Mas, Eric ^a,b,c,d  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT DEPENDENT LIPASE; CD40 LIGAND; CD83 ANTIGEN; GLYCOPROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MANNOSE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EMBRYO; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNALIZATION; LYMPHOCYTE PROLIFERATION; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENDOCYTOSIS; HEK293 CELLS; HUMANS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; PANCREATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; STEROL ESTERASE; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 79955028679     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000408     Document Type: Article

References (67)

1. Jemal, A., R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun. 2007. Cancer statistics, 2007. CA Cancer J. Clin. 57: 43-66. (Pubitemid 46148091)
2. Morse, M. A., S. Chui, A. Hobeika, H. K. Lyerly, and T. Clay. 2005. Recent developments in therapeutic cancer vaccines. Nat. Clin. Pract. Oncol. 2: 108-113. (Pubitemid 40790144)
3. Palucka, A. K., H. Ueno, J. W. Fay, and J. Banchereau. 2007. Taming cancer by inducing immunity via dendritic cells. Immunol. Rev. 220: 129-150. (Pubitemid 350045575)
4. Finn, O. J. 2008. Cancer immunology. N. Engl. J. Med. 358: 2704-2715.
5. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252. (Pubitemid 28155090)
6. Palucka, A. K., M. V. Dhodapkar, S. Paczesny, H. Ueno, J. Fay, and J. Banchereau. 2005. Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptidespecific CD8+ T cells in patients with metastatic melanoma. J. Immunother. 28: 158-168. (Pubitemid 40328203)
7. Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immunotherapy: Mapping the way. Nat. Med. 10: 475-480. (Pubitemid 38667904)
8. Napoletano, C., A. Rughetti, M. P. Agervig Tarp, J. Coleman, E. P. Bennett, G. Picco, P. Sale, K. Denda-Nagai, T. Irimura, U. Mandel, et al. 2007. Tumorassociated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. Cancer Res. 67: 8358-8367. (Pubitemid 47395175)
9. Hanisch, F. G., and T. Ninkovic. 2006. Immunology of O-glycosylated proteins: Approaches to the design of a MUC1 glycopeptide-based tumor vaccine. Curr. Protein Pept. Sci. 7: 307-315.
10. Figdor, C. G., Y. van Kooyk, and G. J. Adema. 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2: 77-84. (Pubitemid 37323231)
11. Cambi, A., and C. G. Figdor. 2003. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 15: 539-546. (Pubitemid 37176962)
12. Aarnoudse, C. A., J. J. Garcia Vallejo, E. Saeland, and Y. van Kooyk. 2006. Recognition of tumor glycans by antigen-presenting cells. Curr. Opin. Immunol. 18: 105-111. (Pubitemid 43049656)
13. Vlad, A. M., S. Muller, M. Cudic, H. Paulsen, L. Otvos, Jr., F. G. Hanisch, and O. J. Finn. 2002. Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: Processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells. J. Exp. Med. 196: 1435-1446. (Pubitemid 35424938)
14. Ninkovic, T., L. Kinarsky, K. Engelmann, V. Pisarev, S. Sherman, O. J. Finn, and F. G. Hanisch. 2009. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes. Mol. Immunol. 47: 131-140.
15. van Kooyk, Y., and G. A. Rabinovich. 2008. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 9: 593-601. (Pubitemid 351712630)
16. He, L. Z., A. Crocker, J. Lee, J. Mendoza-Ramirez, X. T. Wang, L. A. Vitale, T. O'Neill, C. Petromilli,H. F. Zhang, J. Lopez, et al. 2007.Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 178: 6259-6267. (Pubitemid 46717409)
17. Engering, A. J., M. Cella, D. M. Fluitsma, E. C. Hoefsmit, A. Lanzavecchia, and J. Pieters. 1997. Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv. Exp. Med. Biol. 417: 183-187. (Pubitemid 27427741)
18. Tan, M. C., A. M. Mommaas, J. W. Drijfhout, R. Jordens, J. J. Onderwater, D. Verwoerd, A. A. Mulder, A. N. van der Heiden, D. Scheidegger, L. C. Oomen, et al. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27: 2426-2435. (Pubitemid 27404330)
19. Sheng, K. C., M. Kalkanidis, D. S. Pouniotis, M. D. Wright, G. A. Pietersz, and V. Apostolopoulos. 2008. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells. J. Immunol. 181: 2455-2464.
20. Dan, J. M., J. P. Wang, C. K. Lee, and S. M. Levitz. 2008. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS ONE 3: E2046.
21. Kerrigan, A. M., and G. D. Brown. 2010. Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol. Rev. 234: 335-352.
22. Chieppa, M., G. Bianchi, A. Doni, A. Del Prete, M. Sironi, G. Laskarin, P. Monti, L. Piemonti, A. Biondi, A. Mantovani, et al. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an antiinflammatory immunosuppressive program. J. Immunol. 171: 4552-4560. (Pubitemid 37310570)
23. Monti, P., B. E. Leone, A. Zerbi, G. Balzano, S. Cainarca, V. Sordi, M. Pontillo, A. Mercalli, V. Di Carlo, P. Allavena, and L. Piemonti. 2004. Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL- 12low regulatory dendritic cell. J. Immunol. 172: 7341-7349. (Pubitemid 38747594)
24. Voigtländer, C., S. Rössner, E. Cierpka, G. Theiner, C. Wiethe, M. Menges, G. Schuler, and M. B. Lutz. 2006. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J. Immunother. 29: 407-415. (Pubitemid 44288953)
25. Hiltbold, E. M., A. M. Vlad, P. Ciborowski, S. C. Watkins, and O. J. Finn. 2000. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J. Immunol. 165: 3730-3741. (Pubitemid 32057279)
26. Rughetti, A., I. Pellicciotta, M. Biffoni, M. Bäckström, T. Link, E. P. Bennet, H. Clausen, T. Noll, G. C. Hansson, J. M. Burchell, et al. 2005. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells. J. Immunol. 174: 7764-7772. (Pubitemid 40806283)
27. Chaput, N., R. Conforti, S. Viaud, A. Spatz, and L. Zitvogel. 2008. The Janus face of dendritic cells in cancer. Oncogene 27: 5920-5931.
28. Kontani, K., O. Taguchi, Y. Ozaki, J. Hanaoka, S. Sawai, S. Inoue, H. Abe, K. Hanasawa, and S. Fujino. 2003. Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin. Int. J. Mol. Med. 12: 493-502.
29. Ramanathan, R. K., K. M. Lee, J. McKolanis, E. Hitbold, W. Schraut, A. J. Moser, E. Warnick, T. Whiteside, J. Osborne, H. Kim, et al. 2005. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunol. Immunother. 54: 254-264. (Pubitemid 40174243)
30. Wierecky, J., M. Mueller, and P. Brossart. 2006. Dendritic cell-based cancer immunotherapy targeting MUC-1. Cancer Immunol. Immunother. 55: 63-67. (Pubitemid 41783295)
31. Escribano, M. J., and S. Imperial. 1989. Purification and molecular characterization of FAP, a feto-acinar protein associated with the differentiation of human pancreas. J. Biol. Chem. 264: 21865-21871. (Pubitemid 20028760)
32. Mas, E., N. Abouakil, S. Roudani, F. Miralles, O. Guy-Crotte, C. Figarella, M. J. Escribano, and D. Lombardo. 1993. Human fetoacinar pancreatic protein: An oncofetal glycoform of the normally secreted pancreatic bile-salt-dependent lipase. Biochem. J. 289: 609-615. (Pubitemid 23042078)
33. Lombardo, D., O. Guy, and C. Figarella. 1978. Purification and characterization of a carboxyl ester hydrolase from human pancreatic juice. Biochim. Biophys. Acta 527: 142-149. (Pubitemid 9055833)
34. Escribano, M. J., J. Cordier, M. Nap, F. J. W. Ten Kate, and P. Burtin. 1986. Differentiation antigens in fetal human pancreas. Reexpression in cancer. Int. J. Cancer 38: 155-160. (Pubitemid 16043589)
35. Mazo, A., Y. Fujii, J. Shimotake, and M. J. Escribano. 1991. Expression of fetoacinar pancreatic (FAP) protein in the pancreatic human tumor cell line BxPC-3. Pancreas 6: 37-45.
36. Miralles, F., F. Langa, A. Mazo, and M. J. Escribano. 1993. Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells. Eur. J. Cell Biol. 60: 115-121. (Pubitemid 23092669)
37. Panicot-Dubois, L., M. Aubert, C. Franceschi, E. Mas, F. Silvy, C. Crotte, J. P. Bernard, D. Lombardo, and M. O. Sadoulet. 2004. Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts. Neoplasia 6: 713-724. (Pubitemid 40041489)
38. Mas, E., C. Crotte, D. Lecestre, J. C. Michalski, M. J. Escribano, D. Lombardo, and M. O. Sadoulet. 1997. The oncofetal J28 epitope involves fucosylated Olinked oligosaccharide structures of the fetoacinar pancreatic protein. Glycobiology 7: 745-752. (Pubitemid 27385372)
39. Panicot, L., E. Mas, E. Pasqualini, M. Zerfaoui, D. Lombardo, M. O. Sadoulet, and A. El Battari. 1999a. The formation of the oncofetal J28 glycotope involves core-2 b6-N-acetylglucosaminyltransferase and a3/4-fucosyltransferase activities. Glycobiology 9: 935-946. (Pubitemid 29435867)
40. Mas, E., E. Pasqualini, N. Caillol, A. El Battari, C. Crotte, D. Lombardo, and M. O. Sadoulet. 1998. Fucosyltransferase activities in human pancreatic tissue: Comparative study between cancer tissues and established tumoral cell lines. Glycobiology 8: 605-613. (Pubitemid 28270582)
41. Brockhausen, I. 1999. Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473: 67-95.
42. Panicot, L., E. Mas, C. Thivolet, and D. Lombardo. 1999b. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes. Diabetes 48: 2316-2323. (Pubitemid 30395422)
43. Benkoël, L., J. P. Bernard, M. J. Payan-Defais, L. Crescence, C. Franceschi, M. Delmas, M. Ouaissi, B. Sastre, J. Sahel, A. M. Benoliel, et al. 2009. Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues. Mol. Cancer Ther. 8: 282-291.
44. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179: 1109-1118.
45. Sadoulet, M. O., C. Franceschi, M. Aubert, F. Silvy, J. P. Bernard, D. Lombardo, and E. Mas. 2007. Glycoengineering of alphaGal xenoantigen on recombinant peptide bearing the J28 pancreatic oncofetal glycotope. Glycobiology 17: 620-630. (Pubitemid 47062705)
46. Pasqualini, E., N. Caillol, L. Panicot, E. Mas, R. Lloubes, and D. Lombardo. 1998. Molecular cloning of the oncofetal isoform of the human pancreatic bile salt-dependent lipase. J. Biol. Chem. 273: 28208-28218. (Pubitemid 28496119)
47. Abouakil, N., E. Rogalska, J. Bonicel, and D. Lombardo. 1988. Purification of pancreatic carboxylic-ester hydrolase by immunoaffinity and its application to the human bile-salt-stimulated lipase. Biochim. Biophys. Acta 961: 299-308.
48. Costello, R. T., F. Mallet, B. Barbarat, J. M. Schiano De Colella, D. Sainty, R. W. Sweet, A. Truneh, and D. Olive. 2003. Stimulation of non-Hodgkin's lymphoma via HVEM: An alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia 17: 2500-2507. (Pubitemid 38072590)
49. Bruneau, N., S. Richard, F. Silvy, A. Verine, and D. Lombardo. 2003. Lectin-like Ox-LDL receptor is expressed in human INT-407 intestinal cells: Involvement in the transcytosis of pancreatic bile salt-dependent lipase. Mol. Biol. Cell 14: 2861-2875. (Pubitemid 36871527)
50. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
51. Falcone, S., E. Cocucci, P. Podini, T. Kirchhausen, E. Clementi, and J. Meldolesi. 2006. Macropinocytosis: Regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 119: 4758-4769. (Pubitemid 44964272)
52. Taylor, P. R., L. Martinez-Pomares, M. Stacey, H. H. Lin, G. D. Brown, and S. Gordon. 2005. Macrophage receptors and immune recognition. Annu. Rev. Immunol. 23: 901-944. (Pubitemid 40563189)
53. Arndt, S. O., A. B. Vogt, S. Markovic-Plese, R. Martin, G. Moldenhauer, A. Wölpl, Y. Sun, D. Schadendorf, G. J. Hämmerling, and H. Kropshofer. 2000. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 19: 1241-1251. (Pubitemid 30151020)
54. Sadegh-Nasseri, S., M. Chen, K. Narayan, and M. Bouvier. 2008. The convergent roles of tapasin and HLA-DM in antigen presentation. Trends Immunol. 29: 141-147.
55. Carlos, C. A., H. F. Dong, O. M. Howard, J. J. Oppenheim, F. G. Hanisch, and O. J. Finn. 2005. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J. Immunol. 175: 1628-1635. (Pubitemid 41023065)
56. Mukaida, N. 2000. Interleukin-8: An expanding universe beyond neutrophil chemotaxis and activation. Int. J. Hematol. 72: 391-398.
57. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukoc. Biol. 71: 173-183.
58. Morris, M. A., and K. Ley. 2004. Trafficking of natural killer cells. Curr. Mol. Med. 4: 431-438. (Pubitemid 38787011)
59. Acosta, J. C., and J. Gil. 2009. A role for CXCR2 in senescence, but what about in cancer? Cancer Res. 69: 2167-2170.
60. Tesmer, L. A., S. K. Lundy, S. Sarkar, and D. A. Fox. 2008. Th17 cells in human disease. Immunol. Rev. 223: 87-113. (Pubitemid 351986173)
61. Wigmore, S. J., K. C. Fearon, K. Sangster, J. P. Maingay, O. J. Garden, and J. A. Ross. 2002. Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer. Int. J. Oncol. 21: 881-886.
62. Ebrahimi, B., S. L. Tucker, D. Li, J. L. Abbruzzese, and R. Kurzrock. 2004. Cytokines in pancreatic carcinoma: Correlation with phenotypic characteristics and prognosis. Cancer 101: 2727-2736. (Pubitemid 39603180)
63. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036. (Pubitemid 36222922)
64. Tjomsland, V., A. Spångeus, P. Sandström, K. Borch, D. Messmer, and M. Larsson. 2010. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS ONE 5: E13441.
65. Bharadwaj, U., M. Li, R. Zhang, C. Chen, and Q. Yao. 2007. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 67: 5479-5488. (Pubitemid 46997289)
66. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183-1186.
67. Simpson, J. R., J. Ross, T. A. Johnson, and I. A. Amara. 1988. The box-blot: An exploratory analysis graph for biomedical publications. Am. Heart J. 116: 1663-1665.